As a GLP-1 receptor agonist, semaglutide can provide significant benefits when used under the guidance of a healthcare professional
Benefits at a glance: Tirzepatide/Cyanocobalamin - Effective in reducing HbA1c levels, a measure of long-term blood sugar control - Promotes significant weight loss, which is beneficial for individuals with obesity or overweight - Improves insulin sensitivity, leading to better glycemic control - Reduces the risk of cardiovascular events, such as heart attacks or strokes - Convenient once-weekly dosing, providing convenience and adherence to treatment - Demonstrates superior glycemic control compared to other diabetes medications, ensuring better blood sugar management - Well-tolerated with manageable side effects, enhancing patient compliance and satisfaction - Shows promise in reducing liver fat and improving liver health, which can have significant implications for individuals with fatty liver disease or non-alcoholic steatohepatitis (NASH).
9, 2020, pp
Healthcare providers should counsel patients that fertility may improve during treatment, emphasizing the importance of reliable contraception
A 2022 study published in The Journal of Clinical Endocrinology & Metabolism found that patients with type 2 diabetes using GLP-1 medications reported lower levels of depression and anxiety symptoms (Lee et al., 2022)